Aisling Capital as of March 31, 2017
Portfolio Holdings for Aisling Capital
Aisling Capital holds 17 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 32.1 | $176M | 4.2M | 42.08 | |
| Zeltiq Aesthetics | 16.3 | $90M | 1.6M | 55.61 | |
| Aimmune Therapeutics | 11.8 | $65M | 3.0M | 21.73 | |
| Viewray (VRAYQ) | 11.6 | $64M | 7.5M | 8.51 | |
| Versartis | 7.9 | $43M | 2.0M | 21.35 | |
| Esperion Therapeutics (ESPR) | 5.4 | $30M | 837k | 35.31 | |
| Adma Biologics (ADMA) | 3.2 | $18M | 3.6M | 4.88 | |
| T2 Biosystems | 2.7 | $15M | 2.8M | 5.26 | |
| Transenterix | 1.8 | $10M | 8.3M | 1.21 | |
| Paratek Pharmaceuticals | 1.7 | $9.3M | 483k | 19.25 | |
| Syros Pharmaceuticals | 1.5 | $8.1M | 509k | 15.93 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.4 | $8.0M | 1.0M | 7.80 | |
| Agile Therapeutics | 1.1 | $5.8M | 1.8M | 3.20 | |
| Intersect Ent | 0.7 | $3.9M | 225k | 17.15 | |
| Chimerix (CMRX) | 0.6 | $3.0M | 473k | 6.38 | |
| Pernix Therapeutics Holdings | 0.1 | $777k | 210k | 3.70 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $700k | 2.5M | 0.28 |
